IRLAB Therapeutics AB
STO:IRLAB A
IRLAB Therapeutics AB
STO:IRLAB A
Price:
1.508
SEK
-0.13%
Market Closed
Market Cap:
kr128m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
IRLAB Therapeutics AB
STO:IRLAB A
|
SE |
|
Nanobiotix SA
PAR:NANO
|
FR |
|
SandRidge Energy Inc
NYSE:SD
|
US |
|
E
|
Ero Copper Corp
NYSE:ERO
|
CA |
|
ALK-Abello A/S
CSE:ALK B
|
DK |
|
Barrick Gold Corp
TSX:ABX
|
CA |
|
R
|
RFG Holdings Ltd
JSE:RFG
|
ZA |
|
T
|
Telesat Corp
NASDAQ:TSAT
|
CA |
|
Kingboard Holdings Ltd
HKEX:148
|
HK |
|
M
|
Mao Geping Cosmetics Co Ltd
HKEX:1318
|
CN |
|
Mary Chia Holdings Ltd
SGX:5OX
|
SG |
|
M
|
MTQ Corporation Ltd
SGX:M05
|
SG |
|
W
|
Welspun Enterprises Ltd
NSE:WELENT
|
IN |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is IRLAB A's stock price target?
Not Available
IRLAB A doesn't have any price targets made by Wall Street professionals.
What is IRLAB Therapeutics AB's Revenue forecast?
Projected CAGR
-17%
-17%
For the last 9 years the
compound annual growth rate for
IRLAB Therapeutics AB's revenue is
95%.
The projected
CAGR
for the next 1 year is
-17%.
